Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients
<p>Abstract</p> <p>Background</p> <p>The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. Thi...
Main Authors: | Sigalotti Luca, Covre Alessia, Fratta Elisabetta, Parisi Giulia, Sonego Paolo, Colizzi Francesca, Coral Sandra, Massarut Samuele, Kirkwood John M, Maio Michele |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/10/1/185 |
Similar Items
-
Methylation levels of the "<it>long interspersed nucleotide element-1" </it>repetitive sequences predict survival of melanoma patients
by: Colizzi Francesca, et al.
Published: (2011-05-01) -
Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01) -
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
by: Danielli Riccardo, et al.
Published: (2010-06-01) -
Establishment of Novel DNA Methylation-Based Prostate Cancer Subtypes and a Risk-Predicting Eight-Gene Signature
by: Enchong Zhang, et al.
Published: (2021-02-01) -
Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
by: Bingqi Dong, et al.
Published: (2021-07-01)